- Home
- LRE vs MIRA Comparison
LRE vs MIRA Comparison
Compare LRE & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRE
- MIRA
- Stock Information
- Founded
- LRE 2001
- MIRA 2020
- Country
- LRE Japan
- MIRA United States
- Employees
- LRE 70
- MIRA N/A
- Industry
- LRE
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- LRE
- MIRA Health Care
- Exchange
- LRE Nasdaq
- MIRA Nasdaq
- Market Cap
- LRE 24.4M
- MIRA 19.5M
- IPO Year
- LRE 2023
- MIRA 2023
- Fundamental
- Price
- LRE $1.76
- MIRA $1.30
- Analyst Decision
- LRE
- MIRA Strong Buy
- Analyst Count
- LRE 0
- MIRA 2
- Target Price
- LRE N/A
- MIRA $14.00
- AVG Volume (30 Days)
- LRE 11.2K
- MIRA 2.4M
- Earning Date
- LRE 01-01-0001
- MIRA 08-12-2025
- Dividend Yield
- LRE N/A
- MIRA N/A
- EPS Growth
- LRE N/A
- MIRA N/A
- EPS
- LRE N/A
- MIRA N/A
- Revenue
- LRE $110,330,328.00
- MIRA N/A
- Revenue This Year
- LRE N/A
- MIRA N/A
- Revenue Next Year
- LRE N/A
- MIRA N/A
- P/E Ratio
- LRE N/A
- MIRA N/A
- Revenue Growth
- LRE 3.92
- MIRA N/A
- 52 Week Low
- LRE $1.10
- MIRA $0.57
- 52 Week High
- LRE $2.49
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- LRE 54.52
- MIRA 56.46
- Support Level
- LRE $1.71
- MIRA $1.07
- Resistance Level
- LRE $1.78
- MIRA $1.39
- Average True Range (ATR)
- LRE 0.08
- MIRA 0.10
- MACD
- LRE -0.01
- MIRA 0.00
- Stochastic Oscillator
- LRE 28.78
- MIRA 70.78
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.